Novartis Pipeline Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines. Many of these projects, which include new molecular entities as well ...
CSU affects nearly 4 million people in Europe, with over 50% of patients remaining symptomatic despite H1-antihistamines2-4 ...
. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result ...
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the ...
In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
Phase III program in food allergy (FA) planned for H2 2026 ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Tutvuge allpool olevate Novartise võimalustega. Market Access Manager (80-100%*) (temp role 12 months) Befristet (Innendienst) (Befristet), Full time Strategic Planning & BD&L Switzerland Rotkreuz ...
Sort by Sort ascending Pracovní pozice Seřadit vzestupně Byznys Místo Pobočka Datum zveřejnění Pracovní pozice Seřadit vzestupně Byznys Místo Pobočka Datum zveřejnění Key Account Executive Regulär ...
Marketing Executive Regular, Full time General Management Ireland Dublin (NOCC) 17 Februari 2026 ...
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results